Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-17 5:14 pm Purchase | 13G | ALIGNMENT HEALTHCARE INC ALHC | Flynn James E | 10,865,513 5.68% | 10,865,513 (New Position) | View |
| 2024-05-15 6:39 pm Purchase | 13G | Nuvalent Inc. NUVL | Flynn James E | 25,579,890 33.99% | 102,114 (+0.40%) | View |
| 2024-04-24 5:50 pm Purchase | 13G | Cullinan Therapeutics Inc. CGEM | Flynn James E | 3,283,824 5.71% | 3,283,824 (New Position) | View |
| 2024-04-04 12:52 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | Flynn James E | 3,542,000 5.03% | 3,542,000 (New Position) | View |
| 2024-03-22 5:44 pm Purchase | 13D | BiomX Inc. PHGE | Flynn James E | 6,110,098 11.06% | 6,110,098 (New Position) | View |
| 2024-03-15 4:37 pm Purchase | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 21,273,474 33.32% | 8,300 (+0.04%) | View |
| 2024-02-16 2:11 pm Purchase | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 21,265,174 34.82% | 4,291,539 (+25.28%) | View |
| 2024-02-15 5:20 pm Unchanged | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 16,973,635 39.2% | 0 (Unchanged) | View |
| 2024-02-12 5:34 pm Purchase | 13G | Nuvalent Inc. NUVL | Flynn James E | 25,477,776 35.01% | 6,110 (+0.02%) | View |
| 2024-02-12 5:33 pm Sale | 13G | NUO THERAPEUTICS INC AURX | Flynn James E | 2,183,164 5.16% | -516,836 (-19.14%) | View |
| 2024-02-12 5:33 pm Purchase | 13G | KURA ONCOLOGY INC KURA | Flynn James E | 5,312,733 7.15% | 938,689 (+21.46%) | View |
| 2024-02-12 5:32 pm Purchase | 13G | Merus N.V. MRUS | Flynn James E | 3,019,901 5.23% | 639,463 (+26.86%) | View |
| 2024-02-12 5:32 pm Purchase | 13G | Deciphera Pharmaceuticals Inc. DCPH | Flynn James E | 5,788,024 7.19% | 1,160,714 (+25.08%) | View |
| 2024-02-12 5:31 pm Purchase | 13G | CATALYST PHARMACEUTICALS INC. CPRX | Flynn James E | 8,888,901 8.34% | 3,004,453 (+51.06%) | View |
| 2024-02-12 5:31 pm Sale | 13G | Vigil Neuroscience Inc. VIGL | Flynn James E | 1,173,523 3.27% | -878,487 (-42.81%) | View |
| 2024-02-12 5:31 pm Sale | 13G | Singular Genomics Systems Inc. OMIC | Flynn James E | 7,514,871 6.83% | -401,784 (-5.08%) | View |
| 2024-02-12 5:30 pm Sale | 13G | Pulmonx Corp LUNG | Flynn James E | 6,009 0.02% | -2,459,254 (-99.76%) | View |
| 2024-02-12 5:30 pm Purchase | 13G | Prelude Therapeutics Inc PRLD | Flynn James E | 4,133,000 9.85% | 910,310 (+28.25%) | View |
| 2024-02-12 5:29 pm Purchase | 13G | OWENS & MINOR INC OMI | Flynn James E | 5,229,779 6.84% | 1,027,112 (+24.44%) | View |
| 2024-02-12 5:28 pm Purchase | 13G | Oscar Health Inc. OSCR | Flynn James E | 11,246,820 5.89% | 709,329 (+6.73%) | View |